Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2-Furancarboxamide, 5-nitro-N-[4-[7-(1,2,3,6-tetrahydro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]phenyl] | C25H20F3N5O6 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY153190A5MG

Encompass_Preferred

W1131 TFA is a potent STAT3 inhibitor that induces ferroptosis. It inhibits cancer progression in subcutaneous xenograft, organoid, and PDX models of gastric cancer. W1131 effectively alleviates cancer cell chemoresistance to 5-FU, and regulates the cell cycle, DNA damage response, and oxidative phosphorylation, including the IL6-JAK-STAT3 pathway and the ferroptosis pathway.

  • Potent STAT3 inhibitor
  • Induces ferroptosis
  • Inhibits cancer progression in gastric cancer models
  • Alleviates cancer cell chemoresistance to 5-FU
  • Regulates cell cycle and DNA damage response
  • Regulates oxidative phosphorylation
  • Regulates IL6-JAK-STAT3 pathway
  • Regulates ferroptosis pathway

Catalog No. 50-003-72536


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.